May 7, 2010 — The US Food and Drug Administration (FDA) has issued new dosing guidelines for colchicine (Colcrys tablets; URL Pharma, Inc) when used with protease inhibitors in HIV patients. According ...

Colchicine may be used with caution to manage flare-ups of crystal-induced arthritis among patients with severe chronic kidney disease, with dosage modifications and careful monitoring required.

Gout flares are commonly treated with colchicine, which can provoke GI side effects, particularly diarrhea. The Acute Gout Flare Receiving Colchicine Evaluation (AGREE) trial investigated the efficacy ...

Michael A. Tortorici, Pharm.D.; Barbara Barnes, M.D.; Mary Chester M. Wasko, M.D.; Sue Skledar, M.P.H., B.S.Pharm. Experience with i.v. and oral colchicine at the ...

Scilex Holding Company announced the publication of important dosing adjustments for GLOPERBA®, its liquid oral colchicine product for gout management, in a peer-reviewed journal. GLOPERBA® is unique ...

URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine). These ...

Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) The U.S. Food and Drug Administration today took action against companies that manufacture, ...